SEED INNOVATIONS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.05 GBX | -2.38% |
|
-21.15% | -4.65% |
| 04-17 | EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections | AN |
| 04-16 | Seed Innovations shares boosted by special dividend | AN |
| Sales 2022 | -3.63M -4.55M -363M | Sales 2023 | -3.78M -4.74M -378M | Capitalization | 4.1M 5.14M 410M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -5.02M -400M | Net income 2023 | -4M -5.02M -400M | EV / Sales 2022 | -2.46 x |
| Net cash position 2022 | 922K 1.16M 92.2M | Net cash position 2023 | 30K 37.63K 3M | EV / Sales 2023 | -1.08 x |
| P/E ratio 2022 |
-2.18
x | P/E ratio 2023 |
-0.92
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.18% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.38% | ||
| 1 week | -21.15% | ||
| Current month | +5.13% | ||
| 1 month | +5.13% | ||
| 3 months | -10.87% | ||
| 6 months | -30.51% | ||
| Current year | -4.65% |
1 week
1.96
3.00
1 month
1.913.00
Current year
1.903.00
1 year
1.614.43
3 years
1.619.30
5 years
1.6115.50
10 years
1.6130.40
| Managers | Title | Age | Since |
|---|---|---|---|
Ed McDermott
CEO | Chief Executive Officer | 42 | 12/02/18 |
| Chairman | 62 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 46 | 06/01/20 | |
| Chairman | 62 | - | |
Ed McDermott
CEO | Chief Executive Officer | 42 | 12/02/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2.05 | -2.38% | 2,681,930 |
| 25/04/24 | 2.1 | -27.59% | 7,225,673 |
| 24/04/24 | 2.9 | +3.57% | 2,961,826 |
| 23/04/24 | 2.8 | 0.00% | 5,306,105 |
| 22/04/24 | 2.8 | +7.69% | 4,435,415 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes
Seed Innovations Limited is a Guernsey-based closed-ended investment company. The Company is focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's objective is to invest in disruptive technologies with significant intellectual property rights, which they are seeking to exploit, principally within the technology sector, including digital and content focused businesses; life sciences sectors, including biotech and pharmaceuticals; and health and wellness sectors. It is also focused on providing its investors with exposure to disruptive growth opportunities, with a mix of liquid, pre-liquid, and longer-term investments. The Company invests in companies across various sectors, such as gaming, healthcare, food technology, fintech, cannabidiol (CBD) wellness, and education technology. Beaumont Cornish Limited acts as a nominated adviser to the Company.
Sector
Closed End Funds
| 1st Jan change | Capi. | |
|---|---|---|
| -4.65% | 5.08M | |
| +3.74% | 12.61B | |
| +5.50% | 9.01B | |
| -3.20% | 5.41B | |
| +2.44% | 5.25B | |
| +5.63% | 5.19B | |
| +14.36% | 4.48B | |
| +16.67% | 4.44B | |
| +1.53% | 4B | |
| +1.56% | 3.75B |
- Stock Market
- Equities
- FFWD Stock
